IMM International Metals Mining Corp

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry (the "Company") and Rowing Canada Aviron (RCA) are pleased to
announce a new partnership that sees Immunotec becoming an official sponsor and
supplier of sport performance nutrition supplements to RCA's National Team
athletes as they strive towards podium success in Rio 2016. Immunotec, the
producers of Immunocal(R) Platinum, was recommended by RCA's nutritionists as
part of an overall health and wellness plan.


"Optimizing recovery, performance and wellness in our athletes is crucial to
their ability to achieve international success and Immunotec's supplements play
an important role towards this objective for many of our high performance
athletes," said RCA's Nutritionist, Susan Boegman. 


In addition to supplying the National Team with Immunocal Platinum and other
nutritional products, Immunotec will also partner with RCA to launch a new
program to assist developing clubs and coaches at the community level. Details
of the program will be announced at RCA's National Conference in January.


"We are delighted to be able to be partner with Rowing Canada in support of both
their high performance and community level programs. Improving the athlete's
overall resiliency whether at the national level or club level will allow them
to maximize their potential under the training protocols set forth by their
coaches," said John Molson, Immunotec Vice-President, Research and Development. 


"This is a very beneficial partnership as it directly provides our athletes with
a product of value as well as providing our clubs with the opportunity to learn
from our internationally-renowned coaches," said Donna Atkinson, Rowing Canada
Aviron, Chief Executive Officer. "We have had a relationship for the past year,
but this formal agreement boosts the partnership for both RCA and Immunotec."


Rowing Canada Aviron represents members of all levels of the sport, and runs one
of Canada's most successful summer Olympic-sport programs. For more information
on rowing in Canada and to find your local club, visit rowingcanada.org


About Immunotec Inc. 

Immunotec Inc. is dedicated to making a positive difference in people's health
and lifestyle every day by offering research-driven nutritional products through
its network of Independent Consultants worldwide. Immunotec's products are led
by the flagship brand, Immunocal. Immunocal is a unique, specially-formulated
natural protein product that has been clinically demonstrated and patented to
optimize your immune system. Immunotec's strength comes from its culture that
emphasizes teamwork and entrepreneurial leadership by employees, consultants and
research collaborators.


Headquartered with manufacturing facilities near Montreal, Canada, Immunotec
Consultants generate nearly $50 Million in annual revenue. Please visit us at
www.immunotec.com for additional information.


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. 


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release. 


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward-looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Immunotec Inc.
John Molson
Vice-President, Research and Development
(450) 510-4450


Immunotec Inc.
Patrick Montpetit CPA; CA CF
Vice-President and Chief Financial Officer
(450) 510-4527
www.immunotec.com

International Metals Min... (TSXV:IMM)
Historical Stock Chart
From Apr 2024 to May 2024

International Metals Min... (TSXV:IMM)
Historical Stock Chart
From May 2023 to May 2024